ZA958128B - Viral vectors and use in gene therapy - Google Patents

Viral vectors and use in gene therapy

Info

Publication number: ZA958128B
Authority: ZA; South Africa
Prior art keywords: viral vectors; gene therapy; adenoviruses; relates; gene
Prior art date: 1994-09-27

Application number

ZA958128A

Other languages

English (en)

Inventor

Cecile Orsini

Michel Perricaudet

Emmanuelle Vigne

Patrice Yeh

Original Assignee

Rhone Poulenc Rorer Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-09-27

Filing date

1995-09-27

Publication date

1996-04-24

1995-09-27 Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa

1996-04-24 Publication of ZA958128B publication Critical patent/ZA958128B/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/01—DNA viruses
- C07K14/075—Adenoviridae
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10361—Methods of inactivation or attenuation
- C12N2710/10362—Methods of inactivation or attenuation by genetic engineering
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/108—Plasmid DNA episomal vectors

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Virology (AREA)
Molecular Biology (AREA)
Wood Science & Technology (AREA)
Biophysics (AREA)
Zoology (AREA)
Biochemistry (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Plant Pathology (AREA)
Physics & Mathematics (AREA)
Microbiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Immunology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

ZA958128A 1994-09-27 1995-09-27 Viral vectors and use in gene therapy ZA958128B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9411511A FR2724945B1 (fr)	1994-09-27	1994-09-27	Vecteurs viraux et utilisation en therapie genique

Publications (1)

Publication Number	Publication Date
ZA958128B true ZA958128B (en)	1996-04-24

Family

ID=9467310

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA958128A ZA958128B (en)	1994-09-27	1995-09-27	Viral vectors and use in gene therapy

Country Status (18)

Country	Link
US (1)	US6200798B1 (no)
EP (1)	EP0783585B1 (no)
JP (1)	JPH10506018A (no)
KR (1)	KR100484441B1 (no)
AT (1)	ATE331801T1 (no)
AU (1)	AU712304B2 (no)
CA (1)	CA2197904A1 (no)
DE (1)	DE69535093T2 (no)
DK (1)	DK0783585T3 (no)
ES (1)	ES2268695T3 (no)
FI (1)	FI971275L (no)
FR (1)	FR2724945B1 (no)
IL (1)	IL115432A (no)
MX (1)	MX9701766A (no)
NO (1)	NO319055B1 (no)
PT (1)	PT783585E (no)
WO (1)	WO1996010088A1 (no)
ZA (1)	ZA958128B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU6816194A (en) *	1993-04-20	1994-11-08	Robinson, William S.	Methods and materials for treatment of individuals infected with intracellular infectious agents
AU709498B2 (en) *	1994-12-12	1999-09-02	Genetic Therapy, Inc.	Improved adenoviral vectors and producer cells
AUPN477695A0 (en) *	1995-08-14	1995-09-07	Commonwealth Scientific And Industrial Research Organisation	Gene therapy
FR2753379B1 (fr)	1996-09-13	1998-10-30	Rhone Poulenc Rorer Sa	Methode de traitement de la sclerose laterale amyotrophique
GB9711957D0 (en) *	1997-06-09	1997-08-06	Isis Innovation	Methods and reagents for vaccination
CA2308017A1 (en)	1997-10-30	1999-05-14	Erik S. Falck-Pedersen	A method of inhibiting an immune response to a recombinant vector
CA2340276A1 (en)	1998-08-28	2000-03-09	Duke University	Adenoviruses deleted in the iva2, 100k and/or preterminal protein sequences
FR2794771B1 (fr)	1999-06-11	2001-08-10	Aventis Pharma Sa	Adenovirus recombinants codant pour le transporteur specifique de l'iode (nis)
FR2799472B1 (fr)	1999-10-07	2004-07-16	Aventis Pharma Sa	Preparation d'adenovirus recombinants et de banques adenovirales
AUPR518501A0 (en)	2001-05-22	2001-06-14	Unisearch Limited	Yin yang-1
WO2004018627A2 (en) *	2002-08-22	2004-03-04	Merck & Co., Inc.	Methods for propagating adenovirus and virus produced thereby
SI2002003T1 (sl)	2005-05-27	2016-05-31	Ospedale San Raffaele S.R.L.	Genski vektor, ki vsebuje mi-RNA

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5585362A (en) *	1989-08-22	1996-12-17	The Regents Of The University Of Michigan	Adenovirus vectors for gene therapy
FR2707664B1 (fr) *	1993-07-13	1995-09-29	Centre Nat Rech Scient	Vecteurs viraux et utilisation en thérapie génique.

1994
- 1994-09-27 FR FR9411511A patent/FR2724945B1/fr not_active Expired - Fee Related
1995
- 1995-09-22 AU AU35250/95A patent/AU712304B2/en not_active Ceased
- 1995-09-22 ES ES95932050T patent/ES2268695T3/es not_active Expired - Lifetime
- 1995-09-22 KR KR1019970701945A patent/KR100484441B1/ko not_active Expired - Fee Related
- 1995-09-22 DE DE69535093T patent/DE69535093T2/de not_active Expired - Fee Related
- 1995-09-22 AT AT95932050T patent/ATE331801T1/de not_active IP Right Cessation
- 1995-09-22 PT PT95932050T patent/PT783585E/pt unknown
- 1995-09-22 US US08/809,476 patent/US6200798B1/en not_active Expired - Fee Related
- 1995-09-22 DK DK95932050T patent/DK0783585T3/da active
- 1995-09-22 CA CA002197904A patent/CA2197904A1/fr not_active Abandoned
- 1995-09-22 MX MX9701766A patent/MX9701766A/es not_active IP Right Cessation
- 1995-09-22 JP JP8511437A patent/JPH10506018A/ja not_active Ceased
- 1995-09-22 EP EP95932050A patent/EP0783585B1/fr not_active Expired - Lifetime
- 1995-09-22 WO PCT/FR1995/001228 patent/WO1996010088A1/fr active IP Right Grant
- 1995-09-27 ZA ZA958128A patent/ZA958128B/xx unknown
- 1995-09-27 IL IL115432A patent/IL115432A/en not_active IP Right Cessation
1997
- 1997-03-18 NO NO19971247A patent/NO319055B1/no unknown
- 1997-03-26 FI FI971275A patent/FI971275L/fi unknown

Also Published As

Publication number	Publication date
DE69535093T2 (de)	2007-01-04
ES2268695T3 (es)	2007-03-16
IL115432A (en)	2006-10-05
JPH10506018A (ja)	1998-06-16
FR2724945A1 (fr)	1996-03-29
IL115432A0 (en)	1996-01-31
NO971247L (no)	1997-03-18
AU712304B2 (en)	1999-11-04
EP0783585B1 (fr)	2006-06-28
FR2724945B1 (fr)	1996-12-27
ATE331801T1 (de)	2006-07-15
EP0783585A1 (fr)	1997-07-16
FI971275A0 (fi)	1997-03-26
AU3525095A (en)	1996-04-19
KR970706397A (ko)	1997-11-03
DK0783585T3 (da)	2006-10-23
NO319055B1 (no)	2005-06-13
NO971247D0 (no)	1997-03-18
MX9701766A (es)	1997-06-28
DE69535093D1 (de)	2006-08-10
US6200798B1 (en)	2001-03-13
WO1996010088A1 (fr)	1996-04-04
KR100484441B1 (ko)	2006-01-27
CA2197904A1 (fr)	1996-04-04
PT783585E (pt)	2006-11-30
FI971275L (fi)	1997-03-26

Publication	Publication Date	Title
HUT72558A (en)	1996-05-28	Defective adenovirus vectors and use thereof in gene therapy
MX9603002A (es)	1997-06-28	Procedimiento para la preparacion de virus asociados a los adenovirus (aav), recombinantes, y usos de los mismos.
EP0797436A4 (en)	1999-09-08	INNOVATIVE ADENOVIRAL VECTORS, PACKAGING CELL LINES, RECOMBINANT ADENOVIRUS AND METHOD
ZA942778B (en)	1995-01-09	Recombinant viruses, and their preparation and use in gene therapy.
IL112860A0 (en)	1995-06-29	Recombinant viruses their preparation and their therapeutic uses
MX9702553A (es)	1997-06-28	Adenovirus libres de particulas contaminantes viables, su preparacion y su uso.
FR2712603B1 (fr)	1996-02-09	Virus recombinants, préparation et utilisation en thérapie génique.
MX9705937A (es)	1997-10-31	Procedimiento de preparacion de genoma de adenovirus recombinantes.
ZA958128B (en)	1996-04-24	Viral vectors and use in gene therapy
FR2718150B1 (fr)	1996-04-26	Virus recombinants, préparation et utilisation en thérapie génique.
FR2712602B1 (fr)	1996-02-09	Virus recombinants, préparation et utilisation en thérapie génique.
CA2278808A1 (en)	1998-08-06	Methods for cultivating cells and propagating viruses
FR2717495B1 (fr)	1996-04-12	Virus recombinants, préparation et utilisation en thérapie génique.
AU3611495A (en)	1996-04-26	Adenovirus-derived viral vectors having two therapeutic genes: suicide and immunopotentiating
EP0683229A3 (de)	1996-01-17	Verfahren zur Herstellung von rekombinanten Aprotinin und rekombinanten Aprotinin Varianten mit der natürlichen N-terminalen Sequenz.
IL112992A0 (en)	1995-06-29	Recombinant viruses, their preparation and their use in gene therapy
CA2475337A1 (en)	1998-08-06	Methods for cultivating cells and propagating viruses
FR2720756B1 (fr)	1996-07-12	Virus recombinants, préparation et utilisation en thérapie génique.
IL112994A0 (en)	1995-06-29	Recombinant viruses, their preparation and their use in gene therapy
FR2717823B1 (fr)	1996-04-26	Virus recombinants, préparation et utilisation en thérapie génique.